Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lillicrap

Showing results (41-50 of 132) with videos related to

Pageof 14
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 26, 2012
von Willebrand disease biologyM Blombäck, J Eikenboom, D Lane, et al.
Leukemia Research|January 1, 1991
Absence of allelic loss on chromosome 5q by RFLP analysis in preleukemiaL Shepherd, C Cameron, P Galbraith, et al.
Genomics|January 1, 1992
An A to T transversion at position -5 of the factor IX promoter results in hemophilia BD J Picketts, C D'Souza, P J Bridge, et al.
Molecular and Cellular Biology|May 1, 1996
Binding of the Ets factor GA-binding protein to an upstream site in the factor IX promoter is a critical event in transactivationL M Boccia, D Lillicrap, K Newcombe, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 1, 1988
Lupus anticoagulant, antiphospholipid antibodies and migraineM J Hogan, D G Brunet, P M Ford, et al.
Journal of Thrombosis and Haemostasis : JTH|March 5, 2008
A case of non-resolving hemophilia B Leyden in a 42-year-old male (F9 promoter + 13 A>G)P D James, J Stakiw, J Leggo, et al.
Journal of Thrombosis and Haemostasis : JTH|April 22, 2005
Theoretical structural explanation for Group I and Group II, type 2A von Willebrand disease mutationsL A O'Brien, J J Sutherland, D F Weaver, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 31, 2008
Type 1 von Willebrand disease: application of emerging data to clinical practiceP W Collins, A M Cumming, A C Goodeve, et al.
Journal of Thrombosis and Haemostasis : JTH|March 1, 2016
Canine models of inherited bleeding disorders in the development of coagulation assays, novel protein replacement and gene therapiesT C Nichols, C Hough, H Agersø, et al.
Journal of Thrombosis and Haemostasis : JTH|October 31, 2009
The prevalence of symptomatic von Willebrand disease in primary care practiceM Bowman, W M Hopman, D Rapson, et al.
Pageof 14

Showing results (41-50 of 132) with videos related to

Sort By:
Pageof 14
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 26, 2012
von Willebrand disease biologyM Blombäck, J Eikenboom, D Lane, et al.
Leukemia Research|January 1, 1991
Absence of allelic loss on chromosome 5q by RFLP analysis in preleukemiaL Shepherd, C Cameron, P Galbraith, et al.
Genomics|January 1, 1992
An A to T transversion at position -5 of the factor IX promoter results in hemophilia BD J Picketts, C D'Souza, P J Bridge, et al.
Molecular and Cellular Biology|May 1, 1996
Binding of the Ets factor GA-binding protein to an upstream site in the factor IX promoter is a critical event in transactivationL M Boccia, D Lillicrap, K Newcombe, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 1, 1988
Lupus anticoagulant, antiphospholipid antibodies and migraineM J Hogan, D G Brunet, P M Ford, et al.
Journal of Thrombosis and Haemostasis : JTH|March 5, 2008
A case of non-resolving hemophilia B Leyden in a 42-year-old male (F9 promoter + 13 A>G)P D James, J Stakiw, J Leggo, et al.
Journal of Thrombosis and Haemostasis : JTH|April 22, 2005
Theoretical structural explanation for Group I and Group II, type 2A von Willebrand disease mutationsL A O'Brien, J J Sutherland, D F Weaver, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 31, 2008
Type 1 von Willebrand disease: application of emerging data to clinical practiceP W Collins, A M Cumming, A C Goodeve, et al.
Journal of Thrombosis and Haemostasis : JTH|March 1, 2016
Canine models of inherited bleeding disorders in the development of coagulation assays, novel protein replacement and gene therapiesT C Nichols, C Hough, H Agersø, et al.
Journal of Thrombosis and Haemostasis : JTH|October 31, 2009
The prevalence of symptomatic von Willebrand disease in primary care practiceM Bowman, W M Hopman, D Rapson, et al.
Pageof 14